Drug
Xmt 1107
Xmt 1107: highest development phase Phase 1, developed by Mersana Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Mersana Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| XMT-1107 NCT01011972 | Phase 1 | Neoplasm Metastasis |
Latest
No recent events.
Follow Xmt 1107 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.